Uterine Cancer News and Research

RSS
When cancer starts in the uterus, it is called uterine cancer. The uterus is the pear-shaped organ in a woman's pelvis (the area below your stomach and in between your hip bones). The uterus, also called the womb, is where the baby grows when a woman is pregnant. The most common type of uterine cancer is also called endometrial cancer because it forms in the lining of your uterus, called the endometrium.

When uterine cancer is found early, treatment is most effective. The most common sign of uterine cancer is bleeding that is not normal for you because of when it happens or how heavy it is. This could mean bleeding, even a little bit, after you have gone through menopause; periods that are longer than seven days; bleeding between periods; or any other bleeding that is longer or heavier than is normal for you.

Other symptoms, such as pain or pressure in your pelvis, also may occur if you have uterine cancer. If you have any of these symptoms, talk to your doctor, nurse, or other health care professional right away. They may be caused by something other than cancer, but the only way to know is to see your health care professional.
New study shows wide disparities in access to minimally invasive hysterectomies for uterine cancer

New study shows wide disparities in access to minimally invasive hysterectomies for uterine cancer

Undetected cancer among women undergoing gynecologic surgery more common than previously thought

Undetected cancer among women undergoing gynecologic surgery more common than previously thought

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

Researchers discover new strategy for attacking cancer cells

Researchers discover new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

New study describes multi-method strategy to improve detection of PMS2 gene mutations in Lynch syndrome

New study describes multi-method strategy to improve detection of PMS2 gene mutations in Lynch syndrome

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Nearly 15 million U.S. women have limited access to specialized gynecologic cancer care

Nearly 15 million U.S. women have limited access to specialized gynecologic cancer care

New treatment option for postmenopausal women with non-invasive breast cancer

New treatment option for postmenopausal women with non-invasive breast cancer

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

Researchers discover new biomarker to identify women with uterine cancer

Researchers discover new biomarker to identify women with uterine cancer

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Researchers and medical bodies explore ways to secure funds for womb cancer research

Researchers and medical bodies explore ways to secure funds for womb cancer research

Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

Study shows prevalence of uterine cancer in women undergoing hysterectomy procedure

Study shows prevalence of uterine cancer in women undergoing hysterectomy procedure

Tamoxifen gel stops breast cancer growth without causing dangerous side effects

Tamoxifen gel stops breast cancer growth without causing dangerous side effects